Full Text View
Tabular View
No Study Results Posted
Related Studies
Hydroxyurea to Prevent Stroke in Children With Sickle Cell Anemia and Elevated TCD Flow Velocity
This study has been completed.
Study NCT00402480   Information provided by Duke University

First Received on November 21, 2006.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Stroke
Additional conditions recognized in this trial
Anemia
Anemia, Sickle Cell
Cerebral Infarction
More general conditions related to this trial
Anemia, Hemolytic
Anemia, Hemolytic, Congenital
Brain Diseases
Brain Infarction
Brain Ischemia
Cardiovascular Diseases
Central Nervous System Diseases
Cerebrovascular Disorders
Genetic Diseases, Inborn
Hematologic Diseases
Hemoglobinopathies
Nervous System Diseases
Vascular Diseases
Interventions listed in this trial
Hydroxyurea
More general drug interventions related to this trial
Antineoplastic Agents
Antisickling Agents
Enzyme Inhibitors
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Duke University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services